Bausch + Lomb Corporation
TSX:BLCO.TO · Toronto Stock Exchange
+$0.04 today
Vol 0.00M · Avg 0.00M
Cash Flow
Check whether earnings turn into cash
Use operating cash flow, capital spending, free cash flow, and financing activity to see how much value is left for reinvestment or owners.
Free Cash Flow
Net Income to FCF bridge
Analysis
Analysis will appear once cash flow data is available for this period.
Cash Flow Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$352.0M -15.4% | -$305.0M -23.0% | -$248.0M -1753.3% | $15.0M -92.2% | $193.0M | $487.6M | $476.4M | $465.2M |
| Depreciation & Amortization | $421.0M -3.4% | $436.0M +14.1% | $382.0M +0.8% | $379.0M -8.7% | $415.0M | $374.2M | $1.2B | $631.8M |
| Deferred Income Tax | -$32.0M -220.0% | -$10.0M +0.0% | -$10.0M +88.9% | -$90.0M -177.6% | $116.0M | $1.4B | -$1.5B | $304.2M |
| Stock-Based Compensation | $149.0M +62.0% | $92.0M +24.3% | $74.0M +19.4% | $62.0M +0.0% | $62.0M | $489.0M | $354.6M | -$1.6B |
| Change in Working Capital | $18.0M +120.7% | -$87.0M +69.7% | -$287.0M -1410.5% | -$19.0M -167.9% | $28.0M | $350.4M | -$1.6B | $1.5B |
| Accounts Receivables | -$148.0M +34.8% | -$227.0M -87.6% | -$121.0M -27.4% | -$95.0M +11.2% | -$107.0M | $592.6M | $1.3B | $626.2M |
| Inventory | $38.0M +125.9% | -$147.0M +44.3% | -$264.0M -149.1% | -$106.0M -606.7% | -$15.0M | $1.0B | $1.2B | $1.1B |
| Accounts Payables | $108.0M -14.3% | $126.0M -48.6% | $245.0M +29.6% | $189.0M +16.0% | $163.0M | $948.2M | -$1.5B | $433.0M |
| Other Working Capital | $20.0M -87.6% | $161.0M +209.5% | -$147.0M -2000.0% | -$7.0M +46.2% | -$13.0M | $567.4M | $1.3B | $601.0M |
| Other Non-Cash Items | $79.0M -25.5% | $106.0M +47.2% | $72.0M +3700.0% | -$2.0M -103.4% | $59.0M | $1.4B | -$1.5B | $300.0M |
| Operating Cash Flow | $283.0M +22.0% | $232.0M +1464.7% | -$17.0M -104.9% | $345.0M -60.5% | $873.0M | $7.2B | $8.9B | $10.5B |
| Capital Expenditures | -$349.0M -19.9% | -$291.0M -60.8% | -$181.0M -3.4% | -$175.0M +16.3% | -$209.0M | $664.0M | $1.4B | $697.6M |
| Acquisitions (Net) | $7.0M +105.1% | -$138.0M +92.9% | -$1.9B -4213.3% | -$45.0M -381.3% | $16.0M | $937.0M | $1.1B | $1.3B |
| Purchases of Investments | -$133.0M -1008.3% | -$12.0M +29.4% | -$17.0M +72.6% | -$62.0M -226.3% | -$19.0M | $444.2M | $1.4B | $1.3B |
| Sales of Investments | $8.0M -42.9% | $14.0M -12.5% | $16.0M -27.3% | $22.0M +57.1% | $14.0M | $822.2M | $318.2M | -$1.5B |
| Other Investing Activities | $12.0M -20.0% | $15.0M +7.1% | $14.0M -68.9% | $45.0M +381.3% | -$16.0M | $616.4M | $370.0M | $1.2B |
| Investing Cash Flow | -$455.0M -10.4% | -$412.0M +80.5% | -$2.1B -880.9% | -$215.0M -0.5% | -$214.0M | $4.8B | $6.4B | $5.1B |
| Debt Repayment | $249.0M +23.9% | $201.0M -90.5% | $2.1B -14.0% | $2.5B +8678.6% | $28.0M | $680.8M | $759.2M | $1.1B |
| Common Stock Issued | $0 | $0 | $0 | $0 | $0 | $778.8M | $946.8M | $812.4M |
| Common Stock Repurchased | $0 +100.0% | -$12.0M -20.0% | -$10.0M | $0 | $0 | $351.8M | -$1.6B | $1.5B |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $535.2M | $613.6M | $692.0M |
| Other Financing Activities | -$24.0M -118.2% | -$11.0M +59.3% | -$27.0M +98.9% | -$2.4B -233.8% | -$712.0M | -$1.6B | $1.3B | $1.1B |
| Financing Cash Flow | $225.0M +26.4% | $178.0M -91.4% | $2.1B +2465.4% | $81.0M +111.4% | -$712.0M | $12.2B | $13.9B | -$15.5B |
| Effect of Forex Changes | $12.9M +180.4% | -$16.0M -900.0% | $2.0M +125.0% | -$8.0M +0.0% | -$8.0M | $1.3B | $1.1B | $990.2M |
| Net Change in Cash | $65.9M +465.9% | -$18.0M +60.9% | -$46.0M -122.7% | $203.0M +432.8% | -$61.0M | $3.2B | $4.9B | $6.5B |
| Free Cash Flow | -$66.0M -11.9% | -$59.0M +70.2% | -$198.0M -216.5% | $170.0M -74.4% | $664.0M | $8.6B | -$16.8B | $11.1B |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Curaleaf Holdings, Inc.
TSX:CURA.TO
$3.12B
Trulieve Cannabis Corp.
TRUL.CN
$2.74B
Bausch Health Companies Inc.
TSX:BHC.TO
$2.51B
WELL Health Technologies Corp.
TSX:WELL.TO
$1.12B
Tilray Brands, Inc.
TSX:TLRY.TO
$801.35M
Spectral Medical Inc.
TSX:EDT.TO
$404.92M
Fennec Pharmaceuticals Inc.
TSX:FRX.TO
$366.40M
Zentek Ltd.
ZEN.V
$66.14M
Sona Nanotech Inc.
SONA.CN
$32.60M
Ocumetics Technology Corp.
OTC.V
$30.63M
SEC Filings
Recent regulatory filings
No filings found.
Does BLCO.TO generate free cash flow?
Bausch + Lomb Corporation (BLCO.TO) generated -$65,999,999.00 of free cash flow in fiscal 2025.
How much operating cash flow does BLCO.TO produce?
Operating cash flow was $283.00M, before capital expenditures of $349.00M.
Explore More
Continue the stock analysis
Jump to another research area for this company.